MET and breast cancer: Since taxanes are commonly used to treat other hormonally dependent cancers, we also analyzed the link between STMN1, HGF, MET, and STMN1/MET gene expression signatures and taxane treatment response in an mBC patient cohort using the ROCplot dataset on BC [44].